Gene · 3732
Papers4,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recombinant human KAI1/CD82 attenuates M1 macrophage polarization on LPS-stimulated RAW264.7 cells via blocking TLR4/JNK/NF-κB signal pathway. | BMB Rep | 2023 | 36945827 | Swiss-Prot, curated | PubMed |
| The versatile roles of testrapanins in cancer from intracellular signaling to cell-cell communication: cell membrane proteins without ligands. | Cell Biosci | 2023 | 36941633 | PubTator, text mining | PubMed |
| Multiple Fibroblast Subtypes Contribute to Matrix Deposition in Pulmonary Fibrosis. | Am J Respir Cell Mol Biol | 2023 | 36927333 | PubTator, text mining | PubMed |
| Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines. | ACS Nano | 2023 | 36926834 | PubTator, text mining | PubMed |
| Exosomal circular RNAs: New player in breast cancer progression and therapeutic targets. | Front Genet | 2023 | 36926585 | PubTator, text mining | PubMed |
| MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR. | Breast Cancer Res | 2023 | 36918912 | PubTator, text mining | PubMed |
| Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update. | Appl Microbiol Biotechnol | 2023 | 36917275 | PubTator, text mining | PubMed |
| TIP60 is required for tumorigenesis in non-small cell lung cancer. | Cancer Sci | 2023 | 36916958 | PubTator, text mining | PubMed |
| Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system. | Neurooncol Adv | 2023 | 36915613 | PubTator, text mining | PubMed |
| The Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer's Disease. | J Clin Med | 2023 | 36902671 | PubTator, text mining | PubMed |
| Extracellular Vesicles (EVs) as Crucial Mediators of Cell-Cell Interaction in Asthma. | Int J Mol Sci | 2023 | 36902079 | PubTator, text mining | PubMed |
| Single-cell profiling reveals pathogenic role and differentiation trajectory of granzyme K+CD8+ T cells in primary Sjögren's syndrome. | JCI Insight | 2023 | 36881472 | PubTator, text mining | PubMed |
| Characterization of bone marrow heterogeneity in NK-AML (M4/M5) based on single-cell RNA sequencing. | Exp Hematol Oncol | 2023 | 36879313 | PubTator, text mining | PubMed |
| coda4microbiome: compositional data analysis for microbiome cross-sectional and longitudinal studies. | BMC Bioinformatics | 2023 | 36879227 | PubTator, text mining | PubMed |
| Identification of Hub Genes Associated with Resistance to Prednisolone in Acute Lymphoblastic Leukemia Based on Weighted Gene Co-expression Network Analysis. | Mol Biotechnol | 2023 | 36877306 | PubTator, text mining | PubMed |
| Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer. | iScience | 2023 | 36876126 | PubTator, text mining | PubMed |
| A noncanonical response to replication stress protects genome stability through ROS production, in an adaptive manner. | Cell Death Differ | 2023 | 36869180 | PubTator, text mining | PubMed |
| Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism. | Nucleic Acids Res | 2023 | 36864821 | PubTator, text mining | PubMed |
| TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN. | Signal Transduct Target Ther | 2023 | 36854750 | PubTator, text mining | PubMed |
| Exosome Mediated Cancer Therapeutic Approach:Present Status and Future Prospectives. | Asian Pac J Cancer Prev | 2023 | 36853283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3732/papers?page=22